Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".

Reif A, Anıl Yağcıoğlu AE, Bitter I, Buyze J, Frey R, Fu DJ, Godinov Y, Haggström L, Kambarov Y, Nielsen RE, Oliveira-Maia AJ, von Holt C, Young AH, Cubała WJ

Open source

DOI
10.1016/j.euroneuro.2026.112885
Published
2026 Nov
Container
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.euroneuro.2026.112885,
  title = {Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".},
  author = {Reif A and Anıl Yağcıoğlu AE and Bitter I and Buyze J and Frey R and Fu DJ and Godinov Y and Haggström L and Kambarov Y and Nielsen RE and Oliveira-Maia AJ and von Holt C and Young AH and Cubała WJ},
  year = {2026},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  doi = {10.1016/j.euroneuro.2026.112885},
  url = {https://doi.org/10.1016/j.euroneuro.2026.112885}
}

RIS

TY  - JOUR
TI  - Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".
AU  - Reif A
AU  - Anıl Yağcıoğlu AE
AU  - Bitter I
AU  - Buyze J
AU  - Frey R
AU  - Fu DJ
AU  - Godinov Y
AU  - Haggström L
AU  - Kambarov Y
AU  - Nielsen RE
AU  - Oliveira-Maia AJ
AU  - von Holt C
AU  - Young AH
AU  - Cubała WJ
PY  - 2026
JO  - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
DO  - 10.1016/j.euroneuro.2026.112885
UR  - https://doi.org/10.1016/j.euroneuro.2026.112885
ER  - 

APA

A, R., AE, A. Y., I, B., J, B., R, F., DJ, F., Y, G., L, H., Y, K., RE, N., AJ, O., C, V. H., AH, Y., & WJ, C. (2026). Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2026.112885

Source records